65679 Tabela 1

65679 Tabela 1



labie L Baseline Clinical and Angiographic Core Laboratory Characteristics.*

Characteristic

PCI Group (N = 1082)

Medical Therapy Group (N = 1084)

P Value

Clinical

Age — yr

58.6±10.8

58.7*11.1

0.78

Sex — no. (%)

0.94

Małe

845 (78)

845 (78)

Female

237 (22)

239 (22)

Race or ethnic group — no. (%)f

0.55

White

874 (81)

864 (80)

Black

32 (3)

35(3)

Hispanic

137 (13)

133 (12)

Other

39(4)

52(5)

History — no./total no. (%)

Angina

236/1081 (22)

252/1084 (23)

0.43

Myocardial infarction

127/1082 (12)

117/1084 (11)

0.49

Cerebrovascular disease

46/1081 (4)

32/1084 (3)

0.10

Peripheral-vessel disease

42/1081 (4)

39/1082 (4)

0.73

Heart failure

26/1081 (2)

24/1082 (2)

0.77

PCI

51/1081 (5)

53/1084 (5)

0.85

CABG

5/1082 (0.5)

4/1084 (0.4)

0.74

Diabetes

200/1082 (18)

246/1084 (23)

0.02

Insulin use

63/1082 (6)

59/1084 (5)

0.70

Hypertension

519/1082 (48)

536/1084 (49)

0.49

Current cigarette smoker — no./total no. (%)

423/1082 (39)

427/1084 (39)

0.89

Highest Killip class II through IV during index Ml — no./ total no. (%)

219/1077 (20)

194/1076 (18)

0.17

NYHA classification at randomization — no./total no. (%) 1

898/1079 (83)

900/1081 (83)

0.98

II

181/1079 (17)

181/1081 (17)

New Q waves

720/1082 (67)

727/1084 (67)

0.80

ST-segment elevation

700/1037 (68)

681/1039 (66)

0.34

ST-segment elevation or Q-wave or R-wave loss

939/1082 (87)

932/1084 (86)

0.58

Glomerular filtration ratę — ml/min^;

80.8*21.4

80.6*21.9

0.83

Thrombolytic therapy during first 24 hr after onset of index Ml — no./total no. (%)

225/1081 (21)

195/1084 (18)

0.10

lnterval between Ml and randomization — days|

0.68

Median

8

8

25th percentile, 75th percentile

5, 16

5, 17

Stress test performed — no./total no. (%)1j

290/1082 (27)

299/1084 (28)

0.68

Ischemia in infarct-related artery territory — no./total no. (%)

0.22

Severe (ineligible)

0/290 (0)

1/299 (0.3)

Moderate

27/290 (9)

32/299 (11)

Mild

98/290 (34)

80/299 (27)

Nonę

165/290 (57)

186/299 (62)


Wyszukiwarka

Podobne podstrony:
Tabela 4 labie 3. Primary and Secondary Outcomes.1 2 3 4 Outcome PCI Group (N = 1082} Medical Thera
968 A. Edorh et al. tumors were associated with advanced clinical and histological markers. The esti
tabela slajd7 internet Users and Penetration In Select Countries Worłdwide, 2006 (millions and % of
Conclusive test results through conducted and radiated measurements OTAtests characte
mob influence This card may be played at any limę, and counts as the action for the group it affects
newblood This card may be płaycd at any time, and counts as the action for the group it affects. The
Th# acouttic amittion bahavior of thraa Nawał alłoy steals (HY 80. HY 100 and HY 130) wat charactari
grassrootssupport Crassroots Support Thtt card may be płayed at any time, and counb ał the actwn tor
htdctmw 056 Same thing goes for figures 2 and 2A. Both depict a character reacting to a punch in the
x le-3 x le-3 Boundary Settings - Convection and Conduction (cc) Equation T = T« Sełect by group Int
Ieytbook Design And hYdluatioii The basie characteristics of any school textbook must be presented i
Typ Krótki opis logical Logical array of true and false values char Characters
Typ Krótki opis logical Logical array of true and false values char Characters
20152 Tabela 6 Table 2. Medication Use on Discharge. Medication PCI Group (N = 1071) Medical Therap

więcej podobnych podstron